Questions galore greet candidates on doorsteps

first_imgWhatsApp Twitter Advertisement NewsLocal NewsQuestions galore greet candidates on doorstepsBy admin – February 21, 2011 718 “WHEN are you resigning?”, “who and when will the potholes on that back road be fixed?” and “why wont the Gardai move the thugs hanging around at the end of the street and in the park?”. Just some of the burning questions being asked at the doors to the political canvassing armies that wear their shoe leather on the collective march to the Dail. Sign up for the weekly Limerick Post newsletter Sign Up The man and woman on the street want to know what is going to happen to this country, its financial and economic future. But are they getting answers.James, who describes himself as a father of one in his late 20’s, from one of the “so called regeneration areas”, wants to know what will a new government do to secure his future. “I don’t even feel like voting because they make me so mad with their cars, highly paid jobs and golf dinners. I watch the news and read the papers like everyone else. Do they think they can get away with it all the time. If I carried on and did some of the things they were up to, I’d be in Mulgrave Street behind bars”. Focusing on more personal issues, James says: “Social welfare payments have been cut, the chance of jobs seems unlikely and the hole just looks to be getting bigger”.He seems to be the voice of many that indicate the levels of economic despair are on the increase. It is relevant and pertinent to Joe and Mary Bloggs who are struggling through life. Other questions and topics that remain top of the list include, government ministerial pensions and their worth, and who can fix the HSE, along with policy queries on funding for children with special needs? The IMF hits a chord with a few that are clued into the dynamics of economics and the fiscal reports and policies. The campaigns of the major players are hinging on who can renegotiate a better deal, but many wonder if the EU and the pen pushers behind the IMF funding will even consider sitting at the table to talk after the papers have been signed.Darragh, from the northside of the city, asks: “I want to know will you be travelling abroad on St. Patrick’s Day at my expense and what do you hope to achieve by it,” adding, “Why does the Dail get such long holidays and is it fair on the rest of us?”Quipping as to the chaos caused during the last two major weather freezes that the country has endured, Margaret, from the NCRd, wants to know if we “have enough salt and grit for the next cold snap?”In jest to an online question posted to the Limerick Post Facebook account, Limerick native Dawn Hogan, says she will say to canvassers: “How long will it take you to get away from my door?”And finally, an international flavour to one question fielded by this reporter linking our ex-pats from distant shores to home. Mark, an LIT graduate of the 90s and now based in Missouri in the United States, questions if consideration will ever be given to online voting or something to allow voters based abroad have some say at election time? Others disagree.The results of February 25 next might shed some light on few if not all of those questions. Facebookcenter_img Linkedin Email Print Previous articleTraffic control made easier at two black spotsNext articleLimerick Post online election polls published adminlast_img read more

Litter fines

first_imgEmail Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Limerick Ladies National Football League opener to be streamed live Vanishing Ireland podcast documenting interviews with people over 70’s, looking for volunteers to share their stories WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads Print Previous articleHitchers reunite for gruelling tourNext articleWinning recipe Alan Jacques Sign up for the weekly Limerick Post newsletter Sign Up NewsLocal NewsLitter finesBy Alan Jacques – May 23, 2015 807 Facebook Twitter Advertisement RELATED ARTICLESMORE FROM AUTHOR Limerick’s National Camogie League double header to be streamed live WhatsApp Linkedin ALMOST 800 litter fines were issued by Limerick City and County Council last year taking in a revenue of €36,575. Under the Litter Pollution Acts 1997-2009 an on-the-spot fine of €150 can be issued for any breaches of these Acts, or a fine of €4,000 may be imposed if legal proceedings are initiated. Of the 794 litter fines issued in 2014 only 341 were paid. The local authority initiated 48 prosecutions for non-payment and 30 convictions were secured. Meanwhile, despite several campaigns to combat dog fouling, only two litter fines were issued by Limerick City and County Council last year in relation to dog owners not cleaning up after their pets. Neither were paid and legal proceedings were not initiated. TAGSlimerickLimerick City and County Councillitter finesLitter Pollution Act Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” last_img read more

Most patients could have avoided emergency department

first_imgUniversity Hospital Limerick in Dooradoyle. Pic Emma Jervis / Press 22UP TO 83 per cent of patients who presented to the emergency department at University Hospital Limerick on one day in September could have been dealt with at other assessment units within the hospital group.A study carried out on September 11 by the University Hospital Limerick Group (ULHG) found that the majority of the 171 patients who came to the emergency department could have been seen at another assessment unit or clinic if these had all been operating at peak efficiency.Sign up for the weekly Limerick Post newsletter Sign Up Prof Paul Finucane, chief academic officer at the ULHG said: “We looked at patients admitted over a 24-hour period on that day. We had 171 patients who came to the emergency department over that period. Of those we estimated that 17 per cent needed to be there and the other 83 per cent in theory could have been sorted out elsewhere if the facilities were available.“For example if all three medical assessment units — the acute assessment unit, the surgical assessment unit, the local injuries unit — and the rapid access and outpatient clinics, if all these were operating at peak efficiency, then theoretically 83 per cent of all those who presented at the emergency department  that day could have been seen elsewhere.”Prof Finucane revealed that plans are in place to develop the assessment units further to help ease the burden on the emergency department.Meanwhile, the hospital group launched its Winter Resilience Plan this week.UL Hospitals Group chief executive Prof Colette Cowan, revealed that 54 additional beds are due to be made available at the hospital by November.A ward that had been closed for refurbishments will be reopened, freeing up 24 beds, while a further 30 new beds will come on stream.In addition, a new stroke/neurological unit and a dedicated unit for patients with Cystic Fibrosis are also set to open next month.The units are located at the new Leben Building and have been funded by the JP McManus Pro-Am Committee and voluntary organisations TLC4CF, the Mid West branch of the Parkinson’s Association of Ireland and the Mid-Western Hospitals Development Trust.“Our winter resilience plan, which covers October to March, is about better proofing our organisation against the surges in activity we typically see over the winter period,” commented Prof Cowan.She added that the plan sets out a defined set of actions to be taken by all staff according to a colour-coded alert and escalation system.“It provides a clear understanding for our staff of what to do in every department and service area. It goes further than simply consolidating existing plans and includes a number of important initiatives and specific measures to cope with the increasing number of frail, elderly patients in need of care at this time of year,” she explained.The HSE is also advising patients to visit the emergency department only when necessary and go to their GP or Shannondoc in the first instance. WhatsApp Advertisement TAGSColette CowanfeaturedhealthHSElimerickprof Paul Finucaneuniversity hospital limerick Previous articleLimerick rape trial opensNext articleTV – Something for the weekend John Keogh Linkedin NewsMost patients could have avoided emergency departmentBy John Keogh – October 22, 2015 938 Facebook Limerick Ladies National Football League opener to be streamed live RELATED ARTICLESMORE FROM AUTHORcenter_img Twitter Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Vanishing Ireland podcast documenting interviews with people over 70’s, looking for volunteers to share their stories WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads Print Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” Limerick’s National Camogie League double header to be streamed live Emaillast_img read more

Limerick murder victim’s home destroyed by fire

first_imgNewsLimerick murder victim’s home destroyed by fireBy Staff Reporter – November 17, 2016 1645 Limerick Ladies National Football League opener to be streamed live Billy Lee names strong Limerick side to take on Wicklow in crucial Division 3 clash Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” TAGSGardaílimerickPallasgreenShane Murphy Linkedin WhatsApp Previous article#music #limerick #live Questioning Sample AnswerNext articleBoxing – Limerick fighters prepare for Worlds Staff Reporter Email The Lee Estate house in Limerick was the family home of Shane Murphy who was fatally stabbed in 2015 – Picture Press 22THE family home of Limerick fatal stab victim Shane Murphy was gutted in a fire on Monday night but initial investigations indicate that the fire was not started maliciously.31-year-old Shane Murphy died after he received more than 20 stab wounds at a house party in Pallasgreen last year. Two men are currently in custody awaiting trial before the Central Criminal Court.On Monday afternoon last, three units from Limerick City Fire and Rescue were alerted to a blaze which broke out at Shane’s home in Lee Estate.Sign up for the weekly Limerick Post newsletter Sign Up The blaze took hold at sometime around 2pm and a mother of six was forced to flee the house. She was treated at the scene by Emergency Paramedics from the National Ambulance Service for minor smoke inhalation but her children were not at home when the fire took hold.Initial investigations indicate that the blaze may have started at or near the fireplace.The home was said to have been well alight when the alert went out.Extensive flame and smoke damage was caused to the downstairs section of the home but the blaze was brought under control before spreading to adjoining properties.The home, which had been occupied by Shane Murphy before his death, was now home to a sibling and her family.Gardai are still investigating the incident but they are not treating it as suspicious.Andrew [email protected]center_img Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Facebook RELATED ARTICLESMORE FROM AUTHOR Advertisement Limerick’s National Camogie League double header to be streamed live Twitter WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads Printlast_img read more

More ‘chicken houses’ than social houses built in West Limerick

first_imgFacebook Email Previous articleCalls for closure of Foynes direct provision centreNext articlePutting the focus on 163 homeless children Alan Jacques Print Linkedin Liam Galvin, Fine Gael. Photo: Cian ReinhardtMORE ‘chicken houses’ have been built in West Limerick over the past five years than social houses.That was the claim of Fine Gael councillor Liam Galvin at this month’s meeting of the Newcastle West Municipal District.Sign up for the weekly Limerick Post newsletter Sign Up The Abbeyfeale man urged the council executive to “put a plan in place” to deal with the urgent need for housing in rural Ireland. He called for a briefing to be organised on the issue as a “priority” with both the Housing and Planning departments.“It is about time we built housing in small towns and villages. We need to get round the table and deal with this disaster. We are getting people on the phone in tears every day,” Cllr Galvin commented at last Wednesday’s local authority meeting.“We need to get a plan in place to give people the opportunity to get  a chance in life. They have the right to live in the parishes they grew up in. This is not a lot to ask.“Unless someone drives this, it won’t happen. We need the infrastructure and we need to get people up off their backsides so we can find out where we can build houses. See where there is the capacity and infrastructure to build, but let’s just get on with it.“We’ve taken our eye off the ball. We are the lead agency in providing housing for the district. I don’t think we have built one house in the last few years. We are a million miles away from it,” he claimed.Director of Services for Newcastle West, Gordon Daly, promised that he would facilitate a meeting between councillors and the Planning and Housing departments early in the new year.Cllr Galvin urged Mr Daly to prioritise rural County Limerick for housing.“More chicken houses have been built in the district than we’ve built social houses in the last five years. That’s a frightening statistic,” the Fine Gael man replied.center_img Twitter WhatsApp Advertisement NewsHousingPoliticsMore ‘chicken houses’ than social houses built in West LimerickBy Alan Jacques – December 21, 2019 312 last_img read more

Mayor urges Limerick people to spend online with local businesses

first_img Previous articleTop hotel award comes after 300 staff laid off at Adare ManorNext articleEarls returns as nine Munster players named in Irish squad for Autumn Nations Cup Staff Reporter Mayor Michael Collins.LIMERICK City and County Council has joined forces with Limerick Chamber in a call to support home grown businesses by shopping local and early as the Christmas period approaches.With Level Five Covid restrictions affecting many shops across the city and county, Mayor Michael Collins has asked the people of Limerick to spend their money online with local businesses.Many of these businesses have been supported by the establishment of initiative launched earlier this year. The free online shopping platform was a response by Limerick City and County Council and Limerick Chamber to help Limerick businesses trade while their doors were closed by connecting consumers with local suppliers for their shopping needs.Sign up for the weekly Limerick Post newsletter Sign Up “We have an opportunity to do for the Christmas period what was done for the summer by getting behind local businesses and making sure that they   finish out this very challenging year with our support and encouragement,” Mayor Collins said.“As it is not possible to shop instore with so many businesses over the coming weeks, I would impress on the public to support them online and not immediately think of global online marketplaces as a first option.“Limerick City and County Council made this easier this year with an innovative offering by establishing the platform. Over 225 businesses have participated in this programme and we would ask the public to go to the site to explore the brilliant offering these businesses have. I would also like to call on businesses not yet registered on to do so, it’s free and you’ll be part of a wider Christmas marketing campaign.”Chief Executive of Limerick Chamber, Dee Ryan said: “There’s fantastic choice and quality across Limerick and if we all get behind this initiative, we can give local business the Christmas boost that it deserves.“It’s not alone that we support these businesses but, in doing so, we are supporting employment in Limerick. More than ever, this Christmas period is a time to ‘shop Limerick’,” she said.Local small businesses are being encouraged to avail of training opportunities over the challenging weeks ahead with Limerick Local Enterprise Office. There are still a number of places available on its ‘How to Manage a Retail Business During Uncertain Times’ course.This interactive online workshop that enables independent retailers to go back to their businesses and implement a step by step approach towards ensuring their business succeeds and improves their bottom line.A Trading Online Voucher, which is designed to stimulate a small business to develop its online trading presence is also available through the Limerick LEO with a maximum amount payable of €2,500. It can be used to develop or upgrade an e-commerce website or implement a digital marketing strategy.“Limerick businesses have made incredible efforts this year to support customers with a wide range of initiatives to support public health. The least we can do in return is support them online during what should be the busiest trading time of the year and hopefully moving to these restrictions will make a difference so we all can look forward to a safe Christmas,” Mayor Collins concluded. WhatsApp Facebook Advertisement Twittercenter_img Email BusinessNewsMayor urges Limerick people to spend online with local businessesBy Staff Reporter – November 5, 2020 179 Print Linkedinlast_img read more

Novavax COVID-19 vaccine works, but less so against variants

first_img Facebook WhatsApp Twitter Previous articleLiquid nitrogen leak at Georgia poultry plant kills 6Next articleLiverpool beats Spurs 3-1 to revive faltering title defense Digital AIM Web Support Twitter Pinterest WhatsApp Local NewsBusinessUS Newscenter_img Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated versions of the virus circulating in that country and South Africa. The announcement comes amid worry about whether a variety of vaccines being rolled out around the world will be strong enough to protect against worrisome new variants – and as the world desperately needs new types of shots to boost scarce supplies. The study of 15,000 people in Britain is still underway. But an interim analysis found 62 participants so far have been diagnosed with COVID-19 – only six of them in the group that got vaccine and the rest who received dummy shots. The infections occurred at a time when Britain was experiencing a jump in COVID-19 caused by a more contagious variant. A preliminary analysis found over half of the trial participants who became infected had the mutated version. The numbers are very small, but Novavax said they suggest the vaccine is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant. The findings are based on cases that occurred at least a week after the second dose. “Both those numbers are dramatic demonstrations of the ability of our vaccine to develop a very potent immune response,” Novavax CEO Stanley Erck said in a call with investors late Thursday. Scientists have been even more worried about a variant first discovered in South Africa that carries different mutations. Results from a smaller Novavax study in that country suggests the vaccine does work but not nearly as well as it does against the variant from Britain. The South African study included some volunteers with HIV. Among the HIV-negative volunteers, the vaccine appears 60% effective. Including volunteers with HIV, overall the protection was 49%, the company said. While genetic testing still is underway, so far about 90% of the COVID-19 illnesses found in the South African study appear due to the new mutant. “These are good results. There is reason to be optimistic” about the 60% effectiveness, said Glenda Gray, head of the South African Medical Research Council. Even against the new variant that now causes more than 90% of new cases in that country, “we’re still seeing vaccine efficacy,” she said. More concerning is what the study showed about a totally different question — the chances of people getting COVID-19 a second time, said the leader of the South African study, Shabir Madhi of the University of the Witwatersrand in Johannesburg. Tests suggested that nearly a third of study participants had been previously infected, yet rates of new infections in the placebo group were similar. “Past infection with early variants of the virus in South Africa does not protect” against infection with the new one, he said. “There doesn’t seem to be any protection derived.” Novavax said it needs some additional data before it can seek British authorization for the vaccine’s use, sometime in the next month or so. A larger study in the U.S. and Mexico has enrolled slightly over half of the needed 30,000 volunteers. Novavax said it’s not clear if the Food and Drug Administration will need data from that study, too, before deciding whether to allow U.S. use. Meanwhile, it is starting to develop a version of the vaccine that could more specifically target the mutations found in South Africa, in case health authorities eventually decide that updated dosing is needed. Vaccines against COVID-19 train the body to recognize the new coronavirus, mostly the spike protein that coats it. But the Novavax candidate is made differently than the first shots being used. Called a recombinant protein vaccine, the Maryland company uses genetic engineering to grow harmless copies of the coronavirus spike protein in insect cells. Scientists extract and purify the protein and then mix in an immune-boosting chemical. ——— AP Medical Writer Marilynn Marchione contributed. ——— The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Novavax COVID-19 vaccine works, but less so against variants Facebook TAGS  By Digital AIM Web Support – January 28, 2021 Pinterestlast_img read more

Acronis Empowers Resellers and Service Providers With New Cloud-Focused #CyberFit Partner Program

first_img Pinterest SCHAFFHAUSEN, Switzerland–(BUSINESS WIRE)–Feb 1, 2021– Acronis, a global leader in cyber protection, today unveiled the details of the new Acronis #CyberFit Partner Program. This update to the company’s existing program places increased emphasis on supporting partner development, particularly for cloud-based services, while rewarding service providers and resellers for their expertise, commitment, and growth with Acronis through performance-based benefits and financial compensation. This press release features multimedia. View the full release here: Acronis CEO, Serguei “SB” Beloussov, speaks to partners at the annual Acronis Global Cyber Summit (Photo: Business Wire) Acronis’ cloud ecosystem has more than doubled since 2018 and last year saw the largest growth in the number of new partners, with a 30% increase in the number of active service provider partners during 2020. Now, based on feedback from its partners, Acronis provides a partner program that supports forward-thinking go-to-market strategies – enabling partners to earn more while deploying cloud-based solutions that are uniquely suited to meet their clients’ modern protection challenges. “Acronis makes profitability of our partners a priority. Since the launch of Acronis Cyber Protect last year, we received overwhelmingly positive feedback from partners about the ability to scale their business and increase their IT professionals’ productivity by orders of magnitude. Acronis Cyber Platform enabled partners to automate, customize and deliver cyber protection at a level that was not possible before,” said Serguei “SB” Beloussov, Acronis’ Founder and CEO. “Now, with the introduction of the new #CyberFit Partner Program, focused on Cloud business, partners have all the tools to steadily grow their business and introduce new cyber protection services to their customers.” Acronis enhanced partner program Reimagined as a unified program for service providers and resellers, the Acronis #CyberFit Partner Program now includes:Financial incentives that increase as partners advance within the program’s levels, including rebates and proposal-based market development funds (MDF).Marketing and sales assets, with additional marketing automation tools and renewal tools coming in March 2021.Account management assistance that increases with program level, with dedicated marketing support available to Platinum partners.Enhanced technical support to enable faster response times.Sales and technical training via the Acronis #CyberFit Academy, with courses available both live and online. Given the breadth of the enhanced #CyberFit Partner Program, industry observers have noted that Acronis is clearly providing the support that many in the IT channel are seeking. “In today’s digital-focused world, it is critical for vendors to connect easily and efficiently with partners to optimize the user experience,” said Phil Goodwin, Research Director, IDC. “Acronis’ new #CyberFit Partner Program was designed to create this exact kind of relationship. By enhancing this offering over the past few years, Acronis has demonstrated its commitment to providing total marketing, technical and financial support to its partners now and in the future with a dedication to cyber protection solutions.” Additional enhancements to come Acronis also revealed that beginning in March, partners will be able to engage with a new Partner Portal, a platform that will make account management and communication with Acronis easier than ever. “Our partners’ success is our success,” says Acronis Channel Chief Alex Ruslyakov. “By increasing our sales, marketing, and technical support tools and training, we’re making it easier than ever for partners to protect and delight their customers with Acronis’ world-class cyber protection solutions. Acronis continues to invest in partner development and growth to our mutual benefit.” Today’s launch will be followed by the 2021 Acronis #CyberFit Partner Kickoff event, held virtually on February 2 at 10 a.m. EST. Attendees will learn more about Acronis’ roadmap for 2021 and what to expect over the course of the year — including additional new tools, licensing models, and training opportunities. Acronis will also unveil a new licensing format at the event, which is designed to help partners create new opportunities and new revenue streams by expanding their cyber protection services in the coming year. Registration for the 2021 Acronis #CyberFit Partner Kickoff is now open through the Acronis #CyberFit Events website. Partners react to the enhanced program In announcing the expanded program, many of Acronis’ existing partners have welcomed the announced changes. “We are excited by the new Acronis partner program,” said Kuo Yoong, Cloud Program Manager, Synnex Australia. “This program incentivizes a stronger partnership between Synnex and Acronis partners to further grow Acronis cybersecurity solutions to protect reseller businesses in the evolving threat landscape.” UbiStor, Inc.’s Chief Executive Officer Dan Hill had a similar reaction, saying, “Today, we are all relying on data like never before, and we are at ease knowing our customer’s data is safe and secure with Acronis’ effective and affordable solutions coupled with UbiStor’s 24/7/365 managed services. We are thrilled to be a part of the newly improved Partner Program and excited to take advantage of the new incentives to work closely with Acronis as a partner.” From Germany, Thimo Groneberg, Managing Director at Busymouse said, “We’ve always been able to count on Acronis to understand our company needs. Acronis has now taken that to the next level with their new Partner Program. This program incentivizes a stronger partnership that leaves us safer and more protected from cybercrimes in today’s evolving threat landscape.” About Acronis Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions. With award-winning AI-based anti-malware and blockchain-based data authentication technologies, Acronis protects any environment — from cloud to hybrid to on-premises — at a low and predictable cost. Founded in Singapore in 2003 and incorporated in Switzerland in 2008, Acronis now has more than 1,500 employees in 33 locations in 18 countries. Its solutions are trusted by more than 5.5 million home users and 500,000 companies, including 100% of the Fortune 1000, and top-tier professional sports teams. Acronis products are available through 50,000 partners and service providers in over 150 countries in more than 40 languages. View source version on CONTACT: Kayla Fedorowicz | Public Relations Manager, Americas [email protected] KEYWORD: EUROPE SWITZERLAND UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SOFTWARE MOBILE/WIRELESS NETWORKS INTERNET DATA MANAGEMENT TECHNOLOGY SECURITY OTHER COMMUNICATIONS MARKETING ADVERTISING COMMUNICATIONS OTHER TECHNOLOGY SOURCE: Acronis Copyright Business Wire 2021. PUB: 02/01/2021 09:00 AM/DISC: 02/01/2021 09:01 AM By Digital AIM Web Support – February 1, 2021 Pinterest Previous articleTallgrass Energy Receives 2021 Top Workplaces USA AwardNext articleTips for moving pets — to the White House or yours Digital AIM Web Support WhatsApp Local NewsBusiness Acronis Empowers Resellers and Service Providers With New Cloud-Focused #CyberFit Partner Programcenter_img Facebook Twitter TAGS  Facebook WhatsApp Twitterlast_img read more

The Latest: Study: Cleaner air from lockdowns warmed planet

first_img The Latest: Study: Cleaner air from lockdowns warmed planet Twitter By Digital AIM Web Support – February 2, 2021 WhatsApp Facebook Facebook TAGS  Pinterest Pinterest Twitter Local NewsBusinessUS News Previous articleFormer Odessan helps design new White House logoNext articleOn Baseball: MLB work stoppage in 2022 increasingly likely Digital AIM Web Support WhatsApplast_img read more

Moderna Announces Amendment to Supply Agreement with Switzerland for an Additional 6 Million Doses…

first_img Moderna Announces Amendment to Supply Agreement with Switzerland for an Additional 6 Million Doses of COVID-19 Vaccine Moderna Twitter By Digital AIM Web Support – February 3, 2021 Pinterest Previous articleCannabis Testing Market by Products & Software, Services and End-user – Global Forecast to 2025 – ResearchAndMarkets.comNext articlePowered by Everbridge Statewide Deployment, West Virginia Leads Nation with Nearly 100% of First Round Doses of Vaccine Administered Digital AIM Web Support Facebook TAGS  Pinterestcenter_img CAMBRIDGE, Mass.–(BUSINESS WIRE)–Feb 3, 2021– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the Swiss Federal Government has increased its confirmed order commitment from 7.5 million to 13.5 million doses of the COVID-19 Vaccine Moderna in Switzerland. “We are grateful for the confidence and support shown by the Swiss Federal Government as they increase their supply agreement with us,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Switzerland has played a key role in Moderna’s history, and we are delighted with the support of so many stakeholders as we continue to build Moderna’s first commercial organization outside of North America.” The initial procurement by the Swiss Federal Government for 4.5 million doses was announced on August 7, 2020, and this was subsequently increased to 7.5 million doses on December 8, 2020. The additional 6 million doses announced today will be delivered beginning in the summer of 2021, with an option to receive doses in the first half of 2022 as Moderna explores potential vaccine boosters to address emerging variants. On January 12, 2021, Swissmedic authorized the COVID-19 Vaccine Moderna, according to the ordinary approvals procedure and based on a rolling submission of data and the totality of scientific evidence shared by the Company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30, 2020. About the COVID-19 Vaccine Moderna The COVID-19 Vaccine Moderna (referred to in the U.S. as the Moderna COVID-19 Vaccine) is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from the National Institute of Allergy and Infectious Disease’s (NIAID) Vaccine Research Center. The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the National Institutes of Health (NIH) on February 24, 42 days from sequence selection. The first participant in the NIAID-led Phase 1 study of the Moderna COVID-19 Vaccine was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing. On May 12, the U.S Food and Drug Administration granted the Moderna COVID-19 Vaccine Fast Track designation. On May 29, the first participants in each age cohort: adults ages 18-55 years (n=300) and older adults ages 55 years and above (n=300) were dosed in the Phase 2 study of the vaccine. On July 8, the Phase 2 study completed enrolment. Results from the second interim analysis of the NIH-led Phase 1 study of the Moderna COVID-19 Vaccine in the 56-70 and 71+ age groups were published on September 29 in The New England Journal of Medicine. On July 28, results from a non-human primate preclinical viral challenge study evaluating the vaccine were published in The New England Journal of Medicine. On July 14, an interim analysis of the original cohorts in the NIH-led Phase 1 study of the vaccine was published in The New England Journal of Medicine. On November 30, Moderna announced the primary efficacy analysis of the Phase 3 study of the vaccine conducted on 196 cases. On December 3, a letter to the editor was published in The New England Journal of Medicine reporting that participants in the Phase 1 study of the Moderna COVID-19 Vaccine retained high levels of neutralizing antibodies through 119 days following first vaccination (90 days following second vaccination). Authorized Use The COVID-19 Vaccine Moderna has been granted approval by Swissmedic, the Swiss Agency for Therapeutic Products, based upon the recommendation of the Human Medicines Expert Committee (HMEC), which authorizes the COVID-19 Vaccine Moderna for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 18 years of age and older. About Moderna In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the promising-but-still-unproven field of messenger RNA (mRNA), to an enterprise with its first medicine having treated millions of people, a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic. Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 13 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the Company’s development of a vaccine against the novel coronavirus, and plans for the supply and distribution of the Moderna COVID-19 Vaccine to Switzerland, and the timing of deliveries of the vaccine. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could”, “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by Moderna is still being developed and implemented; the safety, tolerability and efficacy profile of the Moderna COVID-19 Vaccine observed to date may change adversely in ongoing analyses of trial data or subsequent to commercialization; despite having ongoing interactions with the FDA or other regulatory agencies, the FDA or such other regulatory agencies may not agree with the Company’s regulatory approval strategies, components of our filings, such as clinical trial designs, conduct and methodologies, or the sufficiency of data submitted; Moderna may encounter delays in meeting manufacturing or supply timelines or disruptions in its distribution plans for the Moderna COVID-19 Vaccine; whether and when any biologics license applications and/or emergency use authorization applications may be filed and ultimately approved by regulatory authorities; potential adverse impacts due to the global COVID-19 pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions, adverse effects on healthcare systems and disruption of the global economy; and those other risks and uncertainties described under the heading “Risk Factors” in Moderna’s most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date hereof. View source version on CONTACT: Moderna Media: Colleen Hussey Director, Corporate Communications 617-335-1374 [email protected] Investors: Lavina Talukdar Senior Vice President & Head of Investor Relations 617-209-5834 [email protected] KEYWORD: EUROPE SWITZERLAND UNITED STATES NORTH AMERICA MASSACHUSETTS INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL GENERAL HEALTH HEALTH INFECTIOUS DISEASES HOSPITALS CLINICAL TRIALS OTHER HEALTH SOURCE: Moderna, Inc. Copyright Business Wire 2021. PUB: 02/03/2021 08:42 AM/DISC: 02/03/2021 08:42 AM Twitter Facebook Local NewsBusiness WhatsApp WhatsApplast_img read more